Drug costs rise despite value-for-money approach in Australia

Author：  

Publisher： Adis International

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.317, 2001-01, pp. : 2-2

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prescription drug costs are expected to rise by > 18%

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 249, 2000-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Despite limitations, therapeutic drug monitoring may be of value in antiretroviral treatment in HIV-infected patients

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 21, Iss. 7, 2005-07 ,pp. : 24-26

Adis International

Access to resources Recommend Favorite

Value-based approach to US drug spend needed

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 446, 2004-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Psychiatric disorders undertreated despite rise in treatment rate

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 481, 2005-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Cancer drug costs discussed

By  

Inpharma, Vol. 1, Iss. 1460, 2004-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite